Correlation Between Vanda Pharmaceuticals and Biomarin Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Vanda Pharmaceuticals and Biomarin Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vanda Pharmaceuticals and Biomarin Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vanda Pharmaceuticals and Biomarin Pharmaceutical, you can compare the effects of market volatilities on Vanda Pharmaceuticals and Biomarin Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vanda Pharmaceuticals with a short position of Biomarin Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vanda Pharmaceuticals and Biomarin Pharmaceutical.
Diversification Opportunities for Vanda Pharmaceuticals and Biomarin Pharmaceutical
0.27 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Vanda and Biomarin is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Vanda Pharmaceuticals and Biomarin Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biomarin Pharmaceutical and Vanda Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vanda Pharmaceuticals are associated (or correlated) with Biomarin Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biomarin Pharmaceutical has no effect on the direction of Vanda Pharmaceuticals i.e., Vanda Pharmaceuticals and Biomarin Pharmaceutical go up and down completely randomly.
Pair Corralation between Vanda Pharmaceuticals and Biomarin Pharmaceutical
Given the investment horizon of 90 days Vanda Pharmaceuticals is expected to generate 2.06 times more return on investment than Biomarin Pharmaceutical. However, Vanda Pharmaceuticals is 2.06 times more volatile than Biomarin Pharmaceutical. It trades about 0.04 of its potential returns per unit of risk. Biomarin Pharmaceutical is currently generating about -0.03 per unit of risk. If you would invest 382.00 in Vanda Pharmaceuticals on December 2, 2024 and sell it today you would earn a total of 94.00 from holding Vanda Pharmaceuticals or generate 24.61% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Vanda Pharmaceuticals vs. Biomarin Pharmaceutical
Performance |
Timeline |
Vanda Pharmaceuticals |
Biomarin Pharmaceutical |
Vanda Pharmaceuticals and Biomarin Pharmaceutical Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Vanda Pharmaceuticals and Biomarin Pharmaceutical
The main advantage of trading using opposite Vanda Pharmaceuticals and Biomarin Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vanda Pharmaceuticals position performs unexpectedly, Biomarin Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomarin Pharmaceutical will offset losses from the drop in Biomarin Pharmaceutical's long position.Vanda Pharmaceuticals vs. Biomarin Pharmaceutical | Vanda Pharmaceuticals vs. Vaxcyte | Vanda Pharmaceuticals vs. Liquidia Technologies | Vanda Pharmaceuticals vs. Legend Biotech Corp |
Biomarin Pharmaceutical vs. Alnylam Pharmaceuticals | Biomarin Pharmaceutical vs. Exelixis | Biomarin Pharmaceutical vs. Halozyme Therapeutics | Biomarin Pharmaceutical vs. Arrowhead Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |